ClinicalTrials.govpublic full text
Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
chronic myeloproliferative disorders, secondary myelofibrosis, primary myelofibrosis, essential thrombocythemia, polycythemia vera, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801664
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.